Preoperative Risk Evaluation and Per ERAS Intervention in the Chinese Elderly Patients Underwent Spinal Fusion Surgery
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age75+
SponsorXijing Hospital
About this trial
This study aims to evaluate the value of preoperative risk factor evaulation combined with perioperative ERAS measures in improving the clinical prognosis of elderly patients undergo the spinal fusion.
Eligibility criteria
Qualifiers
1.Age ≥75 years old;
2.Have degenerative spinal diseases, including cervical, thoracic and lumbar spine diseases;
3.With severe neurological symptoms fail to conservative treatment and have to undergo the spinal fusion surgery;
4.No serious cognitive impairment (MoCA score ≥8);
Disqualifiers
1.Patients who could not cooperate with doctors to complete preoperative evaluation and postoperative follow-up;
2.Patients requiring spinal intervention due to spinal infection, fracture or metastatic disease;
3.Patients with cerebrovascular accidents in the last 30 days;
4.Patients with hepatic encephalopathy or acute active hepatitis;
Trial design
Treatments tested in this trial
- Multidisciplinary Preoperative Risk Evaluation and the Corresponded Pre ERAS intervention
Treatment groups
5,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Xijing Hospital
Lead sponsor
Shenzhen Hospital of Southern Medical University
Collaborator
Second Xiangya Hospital of Central South University
Collaborator
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Collaborator
Source ClinicalTrials.gov